ClassID:

20663

A61K35/68 - CPC Classification

Classification description:

Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Microorganisms or materials therefrom Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma

Recent Application in this class:
#1
20260053874
2026-02-26

COMPOSITIONS AND METHODS TO IMPROVE SEQUESTRATION OF MYCOTOXINS AND THEIR USE IN DETOXIFICATION OF ANIMAL FEED AND ANIMAL PRODUCTION SYSTEMS

#2
20250057892
2025-02-20

ENGINEERED PARASITES FOR DELIVERING PROTEIN TO THE CENTRAL NERVOUS SYSTEM (CNS)

#3
20250017254
2025-01-16

COMPOSITIONS HAVING HIGH LEVELS OF DPA (n-3) AND METHODS FOR PRODUCING

#4
20240398885
2024-12-05

FULL LIGHT REPAIR

#5
20240350568
2024-10-24

NATURAL WATER-SOLUBLE PLANT COMPOUND WITH ANTIDEPRESSANT AND SLEEP-PROMOTING EFFECTS, AND PREPARATION METHOD AND USE THEREOF

#6
20240207328
2024-06-27

USE OF PLASMODIUM IN PREPARATION OF ANTI-TUMOR PREPARATION FOR USE IN COMBINATION WITH RADIOTHERAPY

#7
20240000825
2024-01-04

USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION

#8
20230277607
2023-09-07

Natural non-pathogenic microorganisms capable of associating glycolipids or lipopeptides and use thereof

#9
20230191283
2023-06-22

CHANNELED FIBERS IN SEPARATION OF BIOLOGICALLY ACTIVE NANOPARTICLES

#10
20230110635
2023-04-13

DRUG FOR PREVENTING AND/OR TREATING BRAIN TUMOR AND APPLICATION THEREOF

#11
20230056702
2023-02-23

REDUCING OXYGEN LEVELS IN THE GASTROINTESTINAL TRACT

#12
20220362330
2022-11-17

Compositions and Methods for Increasing Epithelial Barrier Function

#13
20220233607
2022-07-28

TOXOPLASMA PLATFORM FOR TREATING CANCER

#14
20220226393
2022-07-21

USE OF PARASITES AND EXTRACELLULAR VESICLES OBTAINED FROM PARASITES IN CANCER TREATMENT

#15
20220160790
2022-05-26

Engineered parasites for delivering protein to the central nervous system (CNS)

#16
20220000147
2022-01-06

EICOSAPENTAENOIC ACID-PRODUCING MICROORGANISMS, FATTY ACID COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF

#17
20210393760
2021-12-23

Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine

#18
20210346423
2021-11-11

Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation

#19
20210332322
2021-10-28

Antibiotic-free compositions for the prevention or control of coccidiosis

#20
20210330715
2021-10-28

ANTI-BIOFILM AGENTS AND USES THEREOF

#21
20210315967
2021-10-14

METHODS OF TREATING AN AUTOIMMUNE DISEASE

#22
20210275627
2021-09-09

METHODS AND COMPOSITIONS FOR THE TREATMENT OF RADIATION-RELATED DISORDERS

#23
20210100889
2021-04-08

Preparation of flagellin vaccine adjuvant-based vaccine to induce production of antibody recognizing conformation of antigens, and application thereof

#24
20210000947
2021-01-07

Mucosal adjuvants and delivery systems

#25
20200390826
2020-12-17

Therapeutic or non-therapeutic use of protozoans of the genus as a fungistatic and/or fungicide

#26
20200330568
2020-10-22

NEOSPORA FOR USE IN TREATING CANCER AND INFECTIOUS DISEASES

#27
20200297781
2020-09-24

Composition, A Treatment Method and An Application Thereof

#28
20200197501
2020-06-25

Rabbit coccidiosis vaccine and application thereof

#29
20200147148
2020-05-14

Live attenuated parasitic vaccine

#30
20200121731
2020-04-23

Engineered parasites for delivering protein to the central nervous system (CNS)

#31
20190382712
2019-12-19

Antibiotic-free compositions for the prevention or control of coccidiosis

#32
20190282680
2019-09-19

Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine

#33
20190240594
2019-08-08

Channeled fibers in separation of biologically active nanoparticles

#34
20190231827
2019-08-01

Amoeba therapeutic dressings, biomaterials, and solutions

#35
20190142896
2019-05-16

Methods and compositions for the treatment of radiation-related disorders

#36
20190054127
2019-02-21

ANTIVIRAL AGENT AND ANTIVIRAL FOOD

#37
20190048342
2019-02-14

CROSS-REGULATION OF TYPE I INTERFERON SIGNALING PATHWAYS

#38
20190015458
2019-01-17

A Composition, A Treatment Method and An Application Thereof

#39
20180353580
2018-12-13

for use in treating cancer and infectious diseases

#40
20180311271
2018-11-01

Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation

#41
20180295860
2018-10-18

Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof

#42
20180280450
2018-10-04

METHOD OF PROMOTING IMMUNE HEALTH USING THE WATER-SOLUBLE COMPONENT FROM GENUS EUGLENA ORGANISM

#43
20180133271
2018-05-17

Suppressive agent for rheumatoid arthritis, prophylactic agent for rheumatoid arthritis, therapeutic agent for rheumatoid arthritis, and food for suppressing rheumatoid arthritis

#44
20180000911
2018-01-04

Mosquito saliva protein malaria vaccine

#45
20170319632
2017-11-09

Prophylactic or therapeutic agent for peptic ulcer, food additive for prophylactic or therapeutic use, iNOS expression inhibitor and COX-2 expression inhibitor

#46
20170164639
2017-06-15

Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof

#47
20160017275
2016-01-21

USE OF ATTENUATED PARASITE STRAINS FOR THE PREVENTION AND/OR TREATMENT OF EYE WOUNDS ASSOCIATED WITH AN INFECTION BY TOXOPLASMA GONDII

#48
20150352160
2015-12-10

Therapeutic compositions and methods for treating infections

#49
20150313861
2015-11-05

Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof

#50
20150004099
2015-01-01

Targeting of chondroitin sulfate glycans

#51
20140056850
2014-02-27

DICTYOSTELID AMOEBA AND BIOCONTROL USES THEREOF

#52
20140030227
2014-01-30

Therapeutic amoeba and uses thereof

#53
20130183369
2013-07-18

Means of inducing cellular exocytosis and uses thereof

#54
20120201780
2012-08-09

T. CRUZI-DERIVED NEUROTROPHIC AGENTS AND METHODS OF USE THEREFOR

#55
20120189581
2012-07-26

USE OF TOXOPLASMA AND DERIVED COMPOSITIONS TO PREVENT OR TREAT MICROBIAL INFECTIONS

#56
20120093871
2012-04-19

Modified protozoan expressing at least two variable surface proteins (VSP), a vaccine comprising it and procedures, uses, and methods thereof

#57
20120053117
2012-03-01

PHARMACEUTICAL COMPOSITION, DRUG SCREENING METHOD AND METHOD FOR TREATING MALARIA

#58
20110300106
2011-12-08

Therapeutic amoeba and uses thereof

#59
20110177031
2011-07-21

Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof

#60
20110129883
2011-06-02

INACTIVATION OF GENES OF THE MEP PATHWAY

#61
20100255577
2010-10-07

USE OF A NEW ISOLATE OF NEOSPORA CANINUM FOR THE DEVELOPMENT OF DIAGNOSTIC TESTS AND FOR PREPARATION OF PRODUCTS FOR TREATMENT AND PREVENTION OF THE INFECTION CAUSED BY NEOSPORA

#62
20100183668
2010-07-22

Use of coccidian

#63
20100119613
2010-05-13

PROCESS TO ACTIVATE EXTRACTS DERIVED FROM LIVING ORGANISMS USING LONG WAVE UV IRRADIATION AND COMPOSITIONS COMPRISING SAID ACTIVATED EXTRACT

#64
20090202625
2009-08-13

Trypanosome microsome system and uses thereof

#65
20090191242
2009-07-30

NOVEL HOMEOPATHIC STRAIN COMPRISING A NOSODE FROM A PROTOZOON OF THE GENUS TRYPANOSOMA

#66
20090053266
2009-02-26

Apicomplex vaccine strains of a family of Sarcocystidae

#67
20090010890
2009-01-08

Storage stable compositions of biological materials

#68
20080317787
2008-12-25

Anti-malaria vaccine

#69
20080206267
2008-08-28

Inactivation of genes of the MEP pathway

#70
20080044389
2008-02-21

Method for production of arachidonic acid

#71
20080044388
2008-02-21

Method for production of arachidonic acid

#72
20070238652
2007-10-11

Neutralization of bacterial spores

#73
20070224224
2007-09-27

Protozoan strains of reduced virulence and use thereof

#74
20070026050
2007-02-01

Method for production of arachidonic acid

#75
20060229247
2006-10-12

T. cruzi-derived neurotrophic agents and methods of use therefor

#76
20060099272
2006-05-11

Compositions and kits including dehydrated stinging capsules and methods of producing and using same

#77
20050129723
2005-06-16

Skin care composition that mediates cell to cell communication